Cerevel Therapeutics Holdings Inc - ESG Rating & Company Profile powered by AI
This ESG score for Cerevel Therapeutics Holdings Inc represents the company's reporting of the UN SDGs. Comprehensive Sustainability assessment of Cerevel Therapeutics Holdings Inc are reached by signing up for free. The Disclosure rating includes seventeen United Nations SDGs including: 'Clean Water & Sanitation', 'Responsible Production & Consumption' and 'Life below Water'.
Cerevel Therapeutics Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 1.3, social score of 1.1 and governance score of 4.0.
2.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1551 | Voyager Life PLC | 2.2 | Medium |
| 1551 | Source Natural Foods and Herbal Supplements Ltd | 2.2 | Medium |
| 1571 | Cerevel Therapeutics Holdings Inc | 2.1 | Medium |
| 1571 | Charlotte's Web Holdings Inc | 2.1 | Medium |
| 1571 | Ascendis Pharma A/S | 2.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cerevel Therapeutics Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc offer flexible work?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cerevel Therapeutics Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cerevel Therapeutics Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cerevel Therapeutics Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Cerevel Therapeutics Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cerevel Therapeutics Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cerevel Therapeutics Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.